Martin Barrett will be attending to ELRIG Drug Discovery 2025
October 20, 2025
🌟 Exciting Announcement from
Pharmidex! 🌟
We’re delighted to share that our Head of Business Development,
Martin Barrett, will be attending the upcoming conference:
ELRIG Drug Discovery 2025 (21–22 October 2025 | Liverpool, UK).
Martin will be eager to connect with fellow life-sciences innovators, exchange ideas and explore new collaborations and opportunities to accelerate drug discovery and development.
If you’ll be at the event, we’d love to invite you to meet Martin for a chat about how we can work together.
See you in Liverpool!
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
